Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

19

Revenue 2017

Celgene

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Celgene's 2013 oncology sales performance.

Celgene

The best work in healthcare communications shines at virtual Communiqué Awards

The best work in healthcare communications shines at virtual Communiqué Awards

Raising Awareness of Erythroid Maturation Defect in Europe and Canada by MediTech Media (a part of Nucleus Global) for Celgene – a BMS Company.

HTA guidance from NICE, the SMC and the AWMSG

Celgene has scored a positive recommendation from England’s cost-effectiveness watchdog NICE for Revlimid in follicular lymphoma, chalking up another indication.

trans•PLAN

Sponsored by. by MediTech Media (a part of Nucleus Global) for Celgene – A BMS Company. ... Keeping Maturation on Track. Raising Awareness of Erythroid Maturation Defect in Europe and Canada - by MediTech Media (a part of Nucleus Global) for Celgene

BMS scores EU okay for first-in-class anaemia drug Reblozyl

BMS scores EU okay for first-in-class anaemia drug Reblozyl Drug is one of five of Celgene’s late-stage pipeline drugs with blockbuster potential. ... Bristol-Myers Squibb has chalked up another key approval stemming from its $74bn takeover of Celgene.

Excellence in Pre-Commercialisation Communications

by MediTech Media (a part of Nucleus Global) for Celgene. Ineffective erythropoiesis (IE) is the underlying cause of chronic anaemia in several haematological disorders including myelodysplastic syndromes (MDS), thalassaemia, aplastic anaemia

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Healthcare Media Europe – HME Ltd

HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...

Latest intelligence

The search for treatments for Parkinson’s disease
The research requires resilience but pharma is urged to ‘keep innovating, keep trying’...
Margot Hannah, OPEN Health - A personal perspective of LGBT+ and diversity.
Ditch the Label – it’s just me....
The impact of COVID-19 on clinical trials
As all industry sectors work to assess both the impact and the optimal path forward, the effects are expected to be diverse and long-lasting...

Infographics